JHVEPhoto/iStock Editorial via Getty Images Olink ( NASDAQ: OLK ) rose 2.8% after receiving German antitrust approval for its planned sale to Thermo Fisher ( NYSE: TMO ). The German Federal Cartel Office approved the transaction on Monday, according to a posting on the German antitrust regulator's website.
The approval come after Germany's antitrust regulator moved the review of the $3.1 billion sale to Thermo Fisher ( TMO ) i nto a Phase 2 review in February. The UK's Competition and Markets Authority initiated a Phase 1 review of the combination last month.
The deadline for the decision is July 8. The CMA first disclosed in February that the agency was evaluating the Olink/Thermo. Thermo Fisher ( TMO ) in October agreed to acquire Sweden-based Olink ( OLK ) for $26 per share.
More on Olink, Thermo Fisher Scientific, etc. Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends Thermo Fisher Scientific Inc. (TMO) Presents at Bank of Bank of America Securities 2024 Health Care Conference (Transcript) Thermo Fisher: Storm Weathered, Ready To Grow Again Olink drops after UK antitrust regulator starts review of Thermo Fisher deal Thermo Fisher to distribute Bio-Techne products in Europe.
